Merz is the developer of Memantine, an anti-dementia drug, as well as treatments for Parkinson's Disease and depression.
By YONI TEITZ
Tel Aviv University has licensed an Alzheimer's treatment it developed to Merz Pharmaceuticals, a German producer of Alzheimer's drugs.
Ramot, Tel Aviv University's technology transfer company, raised $8.5 million for research into the treatment in 2003.
Merz is the developer of Memantine, an anti-dementia drug, as well as treatments for Parkinson's Disease and depression.
if(catID != 151){
var cont = `Take Israel home with the new Jerusalem Post Store